Jones Financial Companies
RLAY icon

Jones Financial Companies’s Relay Therapeutics RLAY Stock Holding History

Jones Financial Companies’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.4K Buy
2,448
+2,098
+599% +$30.5K ﹤0.01% 3174
2026
Q1 		$3.36K Buy
350
+196
+127% +$1.75K ﹤0.01% 3985
2025
Q4 		$1.3K Hold
154
– – ﹤0.01% 3954
2025
Q3 		$796 Hold
154
– – ﹤0.01% 3948
2025
Q2 		$508 Hold
154
– – ﹤0.01% 3805
2025
Q1 		$419 Buy
+154
New +$603 ﹤0.01% 3531

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Jones Financial Companies's RLAY Position: Q2 2026 in Review

Jones Financial Companies increased its Relay Therapeutics (RLAY) stake by 599% in Q2 2026, buying an estimated $30.5K and bringing the position to 2,448 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3174.

Jones Financial Companies first reported a position in RLAY in Q1 2025 and has held it in 6 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Jones Financial Companies held 2,448 shares of Relay Therapeutics worth $45.4K as of Q2 2026.
  • Jones Financial Companies bought 2,098 Relay Therapeutics shares in Q2 2026, an estimated $30.5K.
  • Relay Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3174 holding.
  • Jones Financial Companies first reported a position in Relay Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.